Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum

Differentiation

Volumn 77, Issue 4, 2009, Pages 377-385

  Vargas, Karina J ^a   Sarmiento, José M ^a   Ehrenfeld, Pamela ^a   Añazco, Carolina C ^a   Villanueva, Carolina I ^a   Carmona, Pamela L ^a   Brenet, Marianne ^a   Navarro, Javier ^b   Müller Esterl, Werner ^c   González, Carlos B ^a,b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b University of Texas Medical Branch School of Medicine   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Arginine vasopressin; Cerebellar ontogeny; Motion perception; Purkinje cells; Vasopressin receptor

Indexed keywords

UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V2A RECEPTOR; VASOPRESSIN V2B RECEPTOR; ISOPROTEIN; VASOPRESSIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; FEMALE; GRANULE CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; PURKINJE CELL; RAT; ANIMAL; CELL CULTURE; CHO CELL; CLASSIFICATION; CRICETULUS; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HAMSTER; IMMUNOHISTOCHEMISTRY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELLS, CULTURED; CEREBELLUM; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VARIATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTEIN ISOFORMS; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 61649098197     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2008.11.002     Document Type: Article

References (59)

1. Balaban C.D., Fredericks D.A., Wurpel J.N., and Severs W.B. Motor disturbances and neurotoxicity induced by centrally administered somatostatin and vasopressin in conscious rats: interactive effects of two neuropeptides. Brain Res. 445 (1988) 117-129
2. Berson B.S., Berntson G.G., Zipf W., Torello M.W., and Kirk W.T. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis. Endocrinology 113 (1983) 337-343
3. 1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 47 (2005) 503-513
4. Bielsky I.F., and Young L.J. Oxytocin, vasopressin, and social recognition in mammals. Peptides 25 (2004) 1565-1574
5. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 11 (2000) 406-410
6. Bohus B., Borrell J., Koolhaas J.M., Nyakas C., Buwalda B., Compaan J.C., and Roozendaal B. The neurohypophysial peptides, learning, and memory processing. Ann. NY Acad. Sci. 689 (1993) 285-299
7. Brinton R.E., Gee K.W., Wamsley J.K., Davis T.P., and Yamamura H.I. Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography. Proc. Natl. Acad. Sci. USA 81 (1984) 7248-7252
8. Buwalda B., Nyakas C., Koolhaas J.M., and Bohus B. Neuroendocrine and behavioral effects of vasopressin in resting and mild stress conditions. Physiol. Behav. 54 (1993) 947-953
9. Caffe A.R., van Leeuwen F.W., Buijs R.M., and van der Gugten J. Vasopressin and noradrenaline coexistence in the rat locus ceruleus: differential decreases of their levels in distant brain areas after thermal and neurotoxic lesions. Brain Res. 459 (1988) 386-390
10. Cooper K.E., Naylor A.M., and Veale W.L. Evidence supporting a role for endogenous vasopressin in fever suppression in the rat. J. Physiol. 387 (1987) 163-172
11. 2 vasopressin receptor. J. Biol. Chem. 273 (1998) 29462-29468
12. 2 receptor subtype in the central nervous system. Brain Res. 759 (1997) 18-23
13. Choe Y., Son G.H., Lee S., Park E., Moon Y., and Kim K. Cell differentiation of gonadotropin-releasing hormone neurons and alternative RNA splicing of the gonadotropin-releasing hormone transcript. Neuroendocrinology 77 (2003) 282-290
14. Dantzer R. Vasopressin, gonadal steroids and social recognition. Prog. Brain Res. 119 (1998) 409-414
15. de Wied D., Diamant M., and Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol. 14 (1993) 251-302
16. de Wied D., Elands J., and Kovacs G. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?. Proc. Natl. Acad. Sci. USA 88 (1991) 1494-1498
17. de Wied D., Gaffori O., Burbach J.P., Kovacs G.L., and van Ree J.M. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J. Pharmacol. Exp. Ther. 241 (1987) 268-274
18. de Wied D., Gaffori O., van Ree J.M., and de Jong W. Central target for the behavioural effects of vasopressin neuropeptides. Nature 308 (1984) 276-278
19. Diamant M., Baars A.M., Kovacs G.L., and De Wied D. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors. Pharmacol. Biochem. Behav. 47 (1994) 27-32
20. Engelmann M., Bures J., and Landgraf R. Vasopressin administration via microdialysis into the septum interferes with the acquisition of spatial memory in rats. Neurosci. Lett. 142 (1992) 69-72
21. 2 receptor. Pflugers Arch. 429 (1994) 79-89
22. Fitzsimmons M.D., Roberts M.M., Sherman T.G., and Robinson A.G. Models of neurohypophyseal homeostasis. Am. J. Physiol. 262 (1992) R1121-R1130
23. 1a) receptors: gender differences. J. Neuroendocrinol. 14 (2002) 349-353
24. Gonzalez C.B., and Figueroa C.D. Vasopressin and bradykinin receptors in the kidney: implications for tubular function. Biol. Res. 32 (1999) 63-76
25. 1 vasopressin receptors in the rat kidney using anti-receptor antibodies. Kidney Int. 52 (1997) 1206-1215
26. Hallbeck M., Hermanson O., and Blomqvist A. Distribution of preprovasopressin mRNA in the rat central nervous system. J. Comp. Neurol. 411 (1999) 181-200
27. Hashimoto H., Fukui K., Noto T., Nakajima T., and Kato N. Distribution of vasopressin and oxytocin in rat brain. Endocrinol. Jpn. 32 (1985) 89-97
28. Hawthorn J., Ang V.T., and Jenkins J.S. Localization of vasopressin in the rat brain. Brain Res. 197 (1980) 75-81
29. 2 receptor mRNA in rats. Eur. J. Pharmacol. 267 (1994) 71-75
30. 2 receptor mRNA in rat hippocampus. Biochem. Biophys. Res. Commun. 205 (1994) 1702-1706
31. Insel T.R., and Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc. Natl. Acad. Sci. USA 89 (1992) 5981-5985
32. 2 receptor mRNA in rat brain. Differentiation 59 (1995) 163-169
33. Lim M.M., Bielsky I.F., and Young L.J. Neuropeptides and the social brain: potential rodent models of autism. Int. J. Dev. Neurosci. 23 (2005) 235-243
34. Lim M.M., Wang Z., Olazabal D.E., Ren X., Terwilliger E.F., and Young L.J. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 429 (2004) 754-757
35. Maiti A., Shahid Salles K., Grassi S., and Abood L.G. Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum. Pharmacol. Biochem. Behav. 25 (1986) 583-588
36. Maiti A., Shahid Salles K., Grassi S., and Abood L.G. Behavior and receptor changes after kainate lesioning of nodular cerebellum. Pharmacol. Biochem. Behav. 25 (1986) 589-594
37. Marchese A., Mihic S.J., Wu P.H., and Kalant H. Arginine8-vasopressin potentiates the motor incoordinating effects of pentobarbital. Eur. J. Pharmacol. 202 (1991) 341-345
38. McLean I.W., and Nakane P.K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J. Histochem. Cytochem. 22 (1974) 1077-1083
39. + channel and GABAA receptor expression in Bergmann glial cells. J. Neurosci. 14 (1994) 2503-2514
40. Naylor A.M., Cooper K.E., and Veale W.L. Vasopressin and fever: evidence supporting the existence of an endogenous antipyretic system in the brain. Can. J. Physiol. Pharmacol. 65 (1987) 1333-1338
41. Pearlmutter A.F., Costantini M.G., and Loeser B. Characterization of 3H-AVP binding sites in particulate preparations of rat brain. Peptides 4 (1983) 335-341
42. 2 selective ligands. Endocrinology 126 (1990) 1478-1484
43. Pickering B.T., Swann R.W., and Gonzalez C.B. Biosynthesis and processing of neurohypophysial hormones. Pharmacol. Ther. 22 (1983) 143-161
44. 2 receptor by an alternative splice receptor variant. J. Biol. Chem. 279 (2004) 47017-47023
45. Sarmiento J.M., Ehrenfeld P., Anazco C.C., Reyes C.E., Troncoso S., Figueroa C.D., Muller-Esterl W., and Gonzalez C.B. Differential distribution of the vasopressin V receptor along the rat nephron during renal ontogeny and maturation. Kidney Int. 68 (2005) 487-496
46. Sawyer W.H., and Manning M. The development of potent and specific vasopressin antagonists. Kidney Int. Suppl. 26 (1988) S34-S37
47. Stebbins C.L., Bonigut S., Liviakis L.R., and Munch P.A. Vasopressin acts in the area postrema to attenuate the exercise pressor reflex in anesthetized cats. Am. J. Physiol. 274 (1998) H2116-H2122
48. Stebbins C.L., Ortiz-Acevedo A., and Hill J.M. Spinal vasopressin modulates the reflex cardiovascular response to static contraction. J. Appl. Physiol. 72 (1992) 731-738
49. Szczepanska-Sadowska E. Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Regul. Pept. 66 (1996) 65-71
50. Thurston C.L., Campbell I.G., Culhane E.S., Carstens E., and Watkins L.R. Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression. Peptides 13 (1992) 17-25
51. 2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. Endocrinology 141 (2000) 307-314
52. Tribollet E., Goumaz M., Raggenbass M., and Dreifuss J.J. Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain. J. Recept. Res. 11 (1991) 333-346
53. Tribollet E., Goumaz M., Raggenbass M., Dubois-Dauphin M., and Dreifuss J.J. Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Brain Res. Dev. Brain Res. 58 (1991) 13-24
54. van Londen L., Kerkhof G.A., van den Berg F., Goekoop J.G., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., and de Wied D. Plasma arginine vasopressin and motor activity in major depression. Biol. Psychiatry 43 (1998) 196-204
55. Vawter M.P., De Wied D., and Van Ree J.M. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task. Neuropeptides 31 (1997) 489-494
56. Willcox B.J., Poulin P., Veale W.L., and Pittman Q.J. Vasopressin-induced motor effects: localization of a sensitive site in the amygdala. Brain Res. 596 (1992) 58-64
57. Winslow J.T., and Insel T.R. Neuroendocrine basis of social recognition. Curr. Opin. Neurobiol. 14 (2004) 248-253
58. 1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav. Neurosci. 111 (1997) 599-605
59. Yue C., Mutsuga N., Scordalakes E.M., and Gainer H. Studies of oxytocin and vasopressin gene expression in the rat hypothalamus using exon- and intron-specific probes. Am. J. Physiol. 290 (2006) R1233-R1241